Tekla Healthcare Investors is an asset management business based in the US. Tekla Healthcare Investors shares (HQH) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $18.94 – .
Probability of Member receiving $1,000 is a probability of 0.026%; If you don’t make a selection in 45 days, you’ll no longer qualify for the promo. Customer must fund their account with a minimum of $50.00 to qualify. Probability percentage is subject to decrease.
Terms and conditions apply*. For 401k rollovers, existing SoFi IRA members must complete 401k rollovers via this link For SoFi members without a SoFi IRA, a SoFi IRA must first be opened, and 401k rollover must be completed utilizing Capitalize via this link. SoFi and Capitalize will charge no additional fees to process a 401(k) rollover to a SoFi IRA. SoFi is not liable for any costs incurred from the existing 401k provider for rollover. Please check with your 401k provider for any fees or costs associated with the rollover. For IRA contributions, only deposits made via ACH and cash transfer from SoFi Bank accounts are eligible for the match. Click here for the 1% Match terms and conditions.
Trade stocks, ETFs, options, futures and bonds all in one place
$0 commissions on stocks, ETFs and equity options, with low contract fees
Deposit or transfer $10,000+ to earn a 2% Match Bonus. Plus: Get a $100 transfer fee reimbursement on your first brokerage transfer of $2,000 or more. T&C apply.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Tekla Healthcare Investors stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Is Tekla Healthcare Investors stock undervalued or overvalued?
Valuing Tekla Healthcare Investors stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Tekla Healthcare Investors's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Tekla Healthcare Investors's P/E ratio
Tekla Healthcare Investors's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 150x. In other words, Tekla Healthcare Investors shares trade at around 150x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Tekla Healthcare Investors financials
Revenue TTM
$10.2 million
Gross profit TTM
$10.2 million
Return on assets TTM
-0.06%
Return on equity TTM
1.06%
Profit margin
102.16%
Book value
$17.66
Market Capitalization
$1.1 billion
TTM: trailing 12 months
Tekla Healthcare Investors's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Tekla Healthcare Investors.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Tekla Healthcare Investors's total ESG risk score
Total ESG risk: 29.97
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Tekla Healthcare Investors's overall score of 29.97 (as at 12/31/2018) is excellent – landing it in it in the 6th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Tekla Healthcare Investors is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Tekla Healthcare Investors's environmental score
Environmental score: 3.07/100
Tekla Healthcare Investors's environmental score of 3.07 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Tekla Healthcare Investors is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Tekla Healthcare Investors's social score
Social score: 17.72/100
Tekla Healthcare Investors's social score of 17.72 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Tekla Healthcare Investors is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Tekla Healthcare Investors's governance score
Governance score: 9.07/100
Tekla Healthcare Investors's governance score puts it squarely in the 6th percentile of companies rated in the same sector. That could suggest that Tekla Healthcare Investors is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Environmental, social, and governance (ESG) summary
Tekla Healthcare Investors was last rated for ESG on: 2019-01-01.
Total ESG score
29.97
Total ESG percentile
6
Environmental score
3.07
Environmental score percentile
6
Social score
17.72
Social score percentile
6
Governance score
9.07
Governance score percentile
6
Tekla Healthcare Investors share dividends
Dividend payout ratio: 1823.08% of net profits
Recently Tekla Healthcare Investors has paid out, on average, around 1800% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Tekla Healthcare Investors shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Tekla Healthcare Investors's case, that would currently equate to about $2.37 per share.
Tekla Healthcare Investors's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Tekla Healthcare Investors's most recent dividend payout was on 30 December 2018. The latest dividend was paid out to all shareholders who bought their shares by 20 November 2025 (the "ex-dividend date").
Tekla Healthcare Investors share price volatility
Over the last 12 months, Tekla Healthcare Investors's shares have ranged in value from as little as $12.507 up to $19.65. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Tekla Healthcare Investors's is 0.722. This would suggest that Tekla Healthcare Investors's shares are less volatile than average (for this exchange).
Tekla Healthcare Investors overview
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
Frequently asked questions
What percentage of Tekla Healthcare Investors is owned by insiders or institutions? Currently 0.004% of Tekla Healthcare Investors shares are held by insiders and 22.756% by institutions.When does the fiscal year end for Tekla Healthcare Investors? Tekla Healthcare Investors's fiscal year ends in September.Where is Tekla Healthcare Investors based? Tekla Healthcare Investors's address is: 1900 Market Street, Philadelphia, PA, United States, 19103What is Tekla Healthcare Investors's ISIN number? Tekla Healthcare Investors's international securities identification number is: US87911J1034What is Tekla Healthcare Investors's CUSIP number? Tekla Healthcare Investors's Committee on Uniform Securities Identification Procedures number is: 404052961
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
Advertiser disclosure
Finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which Finder receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. Finder compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
How likely would you be to recommend Finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.
